Evidence map›Paper›PMID 30562583›Full record

ArticleFungal genetics and biology : FG & B2019

CRISPR-Cas9 induces point mutation in the mucormycosis fungus Rhizopus delemar.

Gillian O Bruni, Keili Zhong, Soo Chan Lee, Ping Wang

Abstract read
In one paragraph

Article in Fungal genetics and biology : FG & B, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Mucormycosis in 2023: an update on pathogenesis and management.Frontiers in cellular and infection microbiology · 2023
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Recent Advances and Future Directions in the Understanding of Mucormycosis.Frontiers in cellular and infection microbiology · 2022
    Review
  10. Article
  11. Review
  12. Genetic Transformation inJournal of fungi (Basel, Switzerland) · 2021
    Review
  13. Review
  14. Review
  15. CRISPR-Cas9-Based Mutagenesis of the Mucormycosis-Causing FungusInternational journal of molecular sciences · 2020
    Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Gillian O BruniDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Keili ZhongDepartment of Plant Pathology, Nanjing Agricultural University, Nanjing, China.
Soo Chan LeeSouth Texas Center for Emerging Infectious Diseases (STCEID), Department of Biology, University of Texas at San Antonio, San Antonio, TX, USA.
Ping WangDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, USA; Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA. Electronic address: pwang@lsuhsc.edu.
Louisiana State University Health Sciences Center New Orleans · USNanjing Agricultural University · CNTexas Center for Infectious Disease · US

Funding

Genome editing in Rhizopus delemar using using CRISPR-Cas systemsR21AI121451 · NIAID · LSU HEALTH SCIENCES CENTER · PI WANG, PING · 2016 to 2017
$397k
Improvement of genetic analysis in the pathogenic zygomycete Mucor circinelloidesR03AI119617 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LEE, SOO CHAN · 2016 to 2017
$150k
NIAID NIH HHS R03 AI119617NIAID NIH HHS R21 AI121451
6 · The paper itself

Abstract

Rhizopus delemar causes devastating mucormycosis in immunodeficient individuals. Despite its medical importance, R. delemar remains understudied largely due to the lack of available genetic markers, the presence of multiple gene copies due to genome duplication, and mitotically unstable transformants resulting from conventional and limited genetic approaches. The clustered regularly interspaced short palindromic repeat (CRISPR)-associated nuclease 9 (Cas9) system induces efficient homologous and non-homologous break points and generates individual and multiple mutant alleles without requiring selective marker genes in a wide variety of organisms including fungi. Here, we have successfully adapted this technology for inducing gene-specific single nucleotide (nt) deletions in two clinical strains of R. delemar: FGSC-9543 and CDC-8219. For comparative reasons, we first screened for spontaneous uracil auxotrophic mutants resistant to 5-fluoroorotic acid (5-FOA) and obtained one substitution (f1) mutationin the FGSC-9543 strain and one deletion (f2) mutation in the CDC-8219 strain. The f2 mutant was then successfully complemented with a pyrF-dpl200 marker gene. We then introduced a vector pmCas9:tRNA-gRNA that expresses both Cas9 endonuclease and pyrF-specific gRNA into FGSC-9543 and CDC-8219 strains and obtained 34 and 42 5-FOA resistant isolates, respectively. Candidate transformants were successively transferred eight times by propagating hyphal tips prior to genotype characterization. Sequencing of the amplified pyrF allele in all transformants tested revealed a single nucleotide (nt) deletion at the 4th nucleotide before the protospacer adjacent motif (PAM) sequence, which is consistent with CRISPR-Cas9 induced gene mutation through non-homologous end joining (NHEJ). Our study provides a new research tool for investigating molecular pathogenesis mechanisms of R. delemar while also highlighting the utilization of CRISPR-Cas9 technology for generating specific mutants of Mucorales fungi.

Indexed as

Point MutationCRISPR-Associated Protein 9CRISPR-Cas SystemsGenes, FungalGenetic VectorsOrotate PhosphoribosyltransferaseOrotic AcidRhizopusUracil5-fluoroorotic acidCRISPR-Associated Protein 9Orotate PhosphoribosyltransferaseOrotic AcidUracil5-FOA resistant mutationGene-specific mutagenesisMucormycosis pathogenPyrF and PyrG

Identifiers

PMID30562583
PMCPMC6784326
OpenAlexW2904635344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.